Skip to main navigation Skip to search Skip to main content

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

  • Cynthia Ma
  • , Sumithra J. Mandrekar
  • , Steven R. Alberts
  • , Gary A. Croghan
  • , Aminah Jatoi
  • , Joel M. Reid
  • , Lorelei J. Hanson
  • , Laura Bruzek
  • , Angelina D. Tan
  • , Henry C. Pitot
  • , Charles Erlichman
  • , John J. Wright
  • , Alex A. Adjei

Research output: Contribution to journal › Article › peer-review

40   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science